Prosecution Insights
Prosecution Insights
11 pending office actions • 5 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (18%) |
| Double-patenting only | 2 (18%) |
| Double-patenting + other | 2 (18%) |
| Multi-statute (no §101) | 5 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CABRAL, ROBERT S | 2 | 62.6% | +32.4% |
| SEAMAN, D MARGARET M | 1 | 76.6% | +8.0% |
| SAMALA, JAGADISHWAR RAO | 1 | 67.9% | +55.5% |
| SKOKO III, JOHN JOSEPH | 1 | 53.2% | +57.5% |
| SCHLIENTZ, LEAH H | 1 | 41.8% | +38.6% |
| CRAIG, KAILA ANGELIQUE | 1 | 32.8% | +26.5% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.1% |
| WESTERBERG, NISSA M | 1 | 23.3% | +36.8% |
| VU, JAKE MINH | 1 | 40.7% | +27.6% |
| BUTTICE, AUDREY L | 1 | 47.1% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16754400 | METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES | BUTTICE, AUDREY L | 33d |
| 18684103 | RADIOIMMUNOCONJUGATES TARGETING CALRETICULIN FOR USE IN THE TREATMENT OF CANCER | SAMALA, JAGADISHWAR RAO | — |
| 18036723 | METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS | SCHLIENTZ, LEAH H | — |
| 17606226 | COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES | WESTERBERG, NISSA M | — |
| 17293663 | COMBINATION OF RADIOIMMUNOTHERAPY AND IMMUNE CHECKPOINT THERAPY IN THE TREATMENT OF CANCER | VU, JAKE MINH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044356 | METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225 | DONOHUE, SEAN R | 11d overdue |
| 16754400 | METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES | BUTTICE, AUDREY L | 33d |
| 18025849 | TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | CRAIG, KAILA ANGELIQUE | 39d |
| 18806385 | METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES | CABRAL, ROBERT S | — |
| 18684103 | RADIOIMMUNOCONJUGATES TARGETING CALRETICULIN FOR USE IN THE TREATMENT OF CANCER | SAMALA, JAGADISHWAR RAO | — |
| 18557988 | RADIOIMMUNOCONJUGATES DIRECTED TO NKG2D LIGANDS FOR THE TREATMENT OF CANCER | SKOKO III, JOHN JOSEPH | — |
| 18036723 | METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS | SCHLIENTZ, LEAH H | — |
| 17725544 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | CABRAL, ROBERT S | — |
| Art Unit | Apps |
|---|---|
| 1618 | 5 |
| 1625 | 1 |
| 1612 | 1 |
| 1614 | 1 |
| 1647 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18806385 | METHODS FOR TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES | CABRAL, ROBERT S | — | DP | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18610927 | BIFUNCTIONAL CHELATORS AND CONJUGATES | SEAMAN, D MARGARET M | 1625 | §102§112DP | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18684103 | RADIOIMMUNOCONJUGATES TARGETING CALRETICULIN FOR USE IN THE TREATMENT OF CANCER | SAMALA, JAGADISHWAR RAO | — | §102§103 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18557988 | RADIOIMMUNOCONJUGATES DIRECTED TO NKG2D LIGANDS FOR THE TREATMENT OF CANCER | SKOKO III, JOHN JOSEPH | 1612 | DP | Non-Final OA | — | Pending | Oct 30, 2023 |
| 18036723 | METHODS FOR TREATING CANCER USING COMBINATIONS OF EPIGENETIC THERAPIES AND RADIOCONJUGATE TARGETING AGENTS | SCHLIENTZ, LEAH H | 1618 | §102§103 | Non-Final OA | — | Pending | May 12, 2023 |
| 18025849 | TROPHOBLAST GLYCOPROTEIN RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 39d | Pending | Mar 10, 2023 |
| 18044356 | METHOD FOR TREATING ACUTE MYELOID LEUKEMIA USING VENETOCLAX IN CONJUNCTION WITH LINTUZUMAB-AC225 | DONOHUE, SEAN R | 1618 | §103 | Final Rejection | 11d overdue | Pending | Mar 07, 2023 |
| 17725544 | COMBINATION RADIOIMMUNOTHERAPY AND CD47 BLOCKADE IN THE TREATMENT OF CANCER | CABRAL, ROBERT S | 1614 | §103§112DP | Non-Final OA | — | Pending | Apr 20, 2022 |
| 17606226 | COMPOSITIONS AND METHODS OF IMMUNODEPLETION FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT HEMATOLOGICAL DISEASES | WESTERBERG, NISSA M | 1618 | §103§112 | Non-Final OA | — | Pending | Oct 25, 2021 |
| 17293663 | COMBINATION OF RADIOIMMUNOTHERAPY AND IMMUNE CHECKPOINT THERAPY IN THE TREATMENT OF CANCER | VU, JAKE MINH | 1618 | §102§103§112Other | Non-Final OA | — | Pending | May 13, 2021 |
| 16754400 | METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES | BUTTICE, AUDREY L | 1647 | §103§112 | Final Rejection | 33d | Pending | Apr 08, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial